IQVIA examined how state 340B contract pharmacy access bills could affect state and local governments in a Feb. 4 white paper funded by the National Pharmaceutical Council.

Drug Industry-Funded Study Finds 340B Contract Pharmacy Bills Costly to Employer Health Plans and States; Critics Slam Its Methodology and Funding Source

February 21, 2025 Shannon Young, Associate Editor/Senior Writer Views

340B contract pharmacy access bills could cost states millions and employer health plans more, according to a new study funded [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

Drug Industry-Funded Study Finds 340B Contract Pharmacy Bills Costly to Employer Health Plans and States; Critics Slam Its Methodology and Funding Source

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

Drug Industry-Funded Study Finds 340B Contract Pharmacy Bills Costly to Employer Health Plans and States; Critics Slam Its Methodology and Funding Source

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

Site Footer Live